Belgian breakthrough in endometriosis research captures investors’ attention Even though endometriosis impacts millions of women globally, the condition remains poorly understood and researched, leading to delayed diagnosis and […] November 15, 2023 · BioVox
Key steps for impactful communication New advances in the life sciences shouldn’t be kept in the dark. Whether you are an academic publishing a paper, […] November 15, 2023 · BioVox
How the Chair of the Board can empower a first-time biotech CEO January 19, 2024 · V-Bio Ventures
The rise of women’s health It’s been a Barbie world this summer with crowds of pink-clad moviegoers flooding the cinemas. Simultaneously, we’ve been witnessing a […] November 15, 2023 · V-Bio Ventures
Muna Therapeutics: hopeful solutions for memory loss Muna Therapeutics is developing transformative therapies for neurodegenerative diseases. These drugs aim to preserve cognition and enhance the brain’s resilience […] October 17, 2023 · V-Bio Ventures
One event, uniting Belgium’s regions BioWin and MEDVIA are two Belgian organizations which support and promote health innovation in Wallonia and Flanders. This year, these […] October 17, 2023 · Janssen Pharmaceutica
V-Bio Ventures portfolio company Agomab raises $100 million Series C to advance fibrosis-focused pipeline — Round led by Fidelity Management & Research Company with participation from new investors EQT Life Sciences, Canaan and Dawn […] October 11, 2023 · V-Bio Ventures
V-Bio Ventures portfolio company Protealis secures EUR 22 million in oversubscribed B round funding to propel sustainable plant protein seed solutions Ghent, 23 January 2024 – Protealis, a leading innovator in seed solutions for sustainable plant proteins based in Ghent, Belgium, […] January 23, 2024 · V-Bio Ventures
V-Bio Ventures-funded Tanai Therapeutics develops first-in-class therapeutics for obesity Ghent, 6 December 2023 – VIB, Flanders’ leading life sciences institute, together with lead investor V-Bio Ventures has launched a […] December 6, 2023 · V-Bio Ventures
Fund+ Portfolio Company Tubulis Closes Upsized EUR 128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline Financing round co-led by EQT Life Sciences and Nextech Invest1, with participation from current and new leading global biotechnology investors […] March 14, 2024 · Press Release
miDiagnostics announces collaboration with Galapagos to develop closed-flow, ultra-rapid CAR-T sterility test for its point-of-care CAR-T manufacturing platform Leuven, Belgium, November 10, 2023 – miDiagnostics NV, a global technology leader in point-of-care diagnostics, today announced a collaboration agreement […] November 10, 2023 · Press Release
Azalea Vision Secures Prestigious European Innovation Council (EIC) Transition Grant Innovative Smart Contact Lens Developer Awarded €2.5M in Funding for Groundbreaking Ocular Health Technology Ghent, Belgium, March 12th, 2024 – […] March 12, 2024 · Press Release
Belgium needs boldness for healthcare innovation This year, Science for health will explore the inspiring innovations at the interface of biology and technology. The event will […] September 27, 2023 · Janssen Pharmaceutica
Hearts in space: a Belgian story of successful collaboration AstroCardia has developed a heart-on-a-chip to study cardiovascular aging… in space! Trials will begin in 2025 aboard the International Space […] September 26, 2023 · MEDVIA